Previous Page  5 / 16 Next Page
Information
Show Menu
Previous Page 5 / 16 Next Page
Page Background

Page 41

allied

academies

September 20-21, 2017 | Philadelphia, USA

Global summit on

TUBERCULOSIS AND LUNG DISEASE

Int J Respir Med 2017 Volume 2 Issue 2

Northeast India is the easternmost region of India and comprises of Seven Sister

States—Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland

and Tripura—and the Himalayan state of Sikkim. Though there are many studies

characterizing M. tuberculosis isolates from different parts of India, studies highlighting

genotypic diversity among isolates from north east India are rare. The present study

aimed to obtain an initial insight into the predominant spoligotypes prevalent in north

east region. Sputum samples from presumptive MDR patients were received from the

north east states for Drug suseptitibility testing (DST). All specimens were screened

for presence of AFB by Ziehl-Neelsen (ZN) staining. The samples were processed by

N-acetyl-L cysteine - Sodium hydroxide (NALC-NaOH) method. Drug susceptibility

testing (DST) was performed by either Line Probe Assay (Hains, MTBDR plus for RIF and

INH) or by MGIT960 liquid culture system (Becton Dickinson, Sparks, MD) after routine

mycobacterial identification. (RIF; 1 µg/ml, INH; 0.1 µg/ml). 148 isolates randomly

selected from existing stocks were subjected to spoligotyping as per standard protocol

and spoligo patterns obtained were compared to those within the SITVIT2 database.

The age of the patients varied from 10-77 years with mean age of 31 years. 99 (67.0%)

patients were male and 49 (33%) were female with a male female ratio of 2: 1. 28

(19%) isolates were sensitive to both the drugs whereas 107 (72.3%) isolates were

MDR. 8(5.4%) isolates were INH resistant and 2 (1.3%) were mono RIF resistant.

Spoligotyping yielded 31 different patterns, 23 of these were unique (1 isolate only)

whereas 8 patterns containing 125 isolates were clustered (2 or more isolates) with

a clustering rate of 84.45%. SIT 1 predominated in this study with 104/148 (70.2%)

isolates. Apart from SIT 1 there were no major clusters. The predominant family in this

study was found to be Beijing (73.64% of total strains). Other families corresponded

to Central Asian (CAS) and East African Indian (EAI). The Harlem family, the poorly

defined T family and “Manu” were present as minor families. Among 107 MDR

strains, 85 belonged to SIT1. Of these mutation data was available for 67 isolates. For

rifampicin, commonest mutation was at codon S531L of rpoB gene (58/67; 86.5%)

followed by H526Y (2/67; 3.0%) and D516V (2/67; 3.0%). In 5 isolates (7.5%), resistance

was determined by absence of wild type probes alone. For INH high level resistance

corresponding to mutation in codon 315 of Kat G gene occurred in 97.0% (65/67) of

samples whereas low level resistance in -15 promoter region was present in two strain.

According to previous available data EAI and CAS were found to be predominant in

India. High percentage of Beijing genotype in north east India is significantly higher

than the rest of India. Considering the fact that this genotype is the major cause of

outbreaks involving drug resistant variants worldwide, our findings are major cause of

concern for health authorities.

e:

arojyoti@gmail.com

Predominance of

Mycobacterium tuberculosis

Beijing genotype among presumptive multidrug

resistance patients from North East India

Arora J

National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India